The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Indicators of amyloid burden in a population-based study of cognitively normal elderly
Open accessAbstract
OBJECTIVES: Secondary prevention trials in subjects with preclinical Alzheimer disease may require documentation of brain amyloidosis. The identification of inexpensive and noninvasive screening variables that can identify individuals who have significant amyloid accumulation would reduce screening costs. METHODS: A total of 483 cognitively normal (CN) individuals, aged 70-92 years, from the population-based Mayo Clinic Study of Aging, underwent Pittsburgh compound B (PiB)-PET imaging. Logistic regression determined whether age, sex, APOE genotype, family history, or cognitive performance was associated with odds of a PiB retention ratio >1.4 and >1.5. Area under the receiver operating characteristic curve (AUROC) evaluated the discrimination between PiB-positive and -negative subjects. For each characteristic, we determined the number needed to screen in each age group (70-79 and 80-89) to identify 100 participants with PiB >1.4 or >1.5. RESULTS: A total of 211 (44%) individuals had PiB >1.4 and 151 (31%) >1.5. In univariate and multivariate models, discrimination was modest (AUROC ∼0.6-0.7). Multivariately, age and APOE best predicted odds of PiB >1.4 and >1.5. Subjective memory complaints were similar to cognitive test performance in predicting PiB >1.5. Indicators of PiB positivity varied with age. Screening APOE ε4 carriers alone reduced the number needed to screen to enroll 100 subjects with PIB >1.5 by 48% in persons aged 70-79 and 33% in those aged 80-89. CONCLUSIONS: Age and APOE genotype are useful predictors of the likelihood of significant amyloid accumulation, but discrimination is modest. Nonetheless, these results suggest that inexpensive and noninvasive measures could significantly reduce the number of CN individuals needed to screen to enroll a given number of amyloid-positive subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Sex differences in Aβ burden alone have not been reported in older adults,11–13”
From Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults (2019) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“Minimal,6 if any,11,12,36 sex differences have been found cross sectionally in levels of global Aβ burden in clinically normal older adults”
From Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults (2019) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Self-citationFrequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Sperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
Cited by
Sorted by citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citationDefining imaging biomarker cut points for brain aging and Alzheimer's disease
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Gunter, J. L., Senjem, M. L., Jones, D. T., Kantarci, K., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.005 · Cited by 931
Self-citationNiewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J. O., Lau, W., Tissot, A. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.061 · Cited by 622
Rabin, L. A., Initiative, T. A. D. N., Smart, C. M., Crane, P. K., Amariglio, R. E., Berman, L., Boada, M., Buckley, R. F., Chételat, G., Dubois, B., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150154 · Cited by 496
Self-citationBuckley, R. F., Mormino, E. C., Rabin, J. S., Hohman, T. J., Landau, S., Hanseeuw, B. J., Jacobs, H. I. L., Papp, K. V., Amariglio, R. E., Properzi, M. J., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4693 · Cited by 373
Chételat, G., Joie, R. L., Villain, N., Perrotin, A., Sayette, V. D. L., Eustache, F., & Vandenberghe, R. R. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.02.006 · Cited by 363
Meta-analysis of amyloid-cognition relations in cognitively normal older adults
Hedden, T., Oh, H., Younger, A. P., & Patel, T. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828ab35d · Cited by 336
Subjective cognitive decline and risk of MCI
van Harten, A. C., Mielke, M. M., Swenson-Dravis, D. M., Hagen, C. E., Edwards, K. K., Roberts, R. O., Geda, Y. E., Knopman, D. S., & Petersen, R. C. (2018) · Neurology · doi:10.1212/wnl.0000000000005863 · Cited by 323
Self-citationPrevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J., Amyloid Biomarker Study Group, Aarsland, D., Alcolea, D., Altomare, D., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2021.5216 · Cited by 290
Buckley, R. F., Mormino, E. C., Amariglio, R. E., Properzi, M. J., Rabin, J. S., Lim, Y. Y., Papp, K. V., Jacobs, H. I. L., Burnham, S., Hanseeuw, B. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.04.010 · Cited by 276
Shi, M., Chu, F., Zhu, F., & Zhu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.870517 · Cited by 275
Atypical aging in down syndrome
Zigman, W. B. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1128 · Cited by 262
Sharma, R. A., Varga, A. W., Bubu, O. M., Pirraglia, E., Kam, K., Parekh, A., Wohlleber, M. E., Miller, M. D., Andrade, A. G., Lewis, C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0704oc · Cited by 259
Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
Petrou, M., Dwamena, B. A., Foerster, B. R., MacEachern, M. P., Bohnen, N. I., Müller, M. L., Albin, R. L., & Frey, K. A. (2015) · Movement Disorders · doi:10.1002/mds.26191 · Cited by 208
Amyloid burden and neural function in people at risk for Alzheimer's Disease
Johnson, S. C., Christian, B. T., Okonkwo, O. C., Oh, J. M., Harding, S., Xu, G., Hillmer, A. T., Wooten, D. W., Murali, D., Barnhart, T. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.028 · Cited by 218
Buckley, R. F., Maruff, P. T., Ames, D. J., Bourgeat, P., Martins, R. N., Masters, C. L., Rainey‐Smith, S. R., Lautenschlager, N. T., Rowe, C. C., Savage, G. R., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.12.013 · Cited by 205
Perrotin, A., La Joie, R., de La Sayette, V., Barré, L., Mézenge, F., Mutlu, J., Guilloteau, D., Egret, S., Eustache, F., & Chételat, G. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.011 · Cited by 179
What did you do yesterday? A meta-analysis of sex differences in episodic memory.
Asperholm, M., Högman, N., Rafi, J., & Herlitz, A. (2019) · Psychological Bulletin · doi:10.1037/bul0000197 · Cited by 182
Gurol, M. E., Viswanathan, A., Gidicsin, C. M., Hedden, T., Martínez‐Ramírez, S., Dumas, A. P., Vashkevich, A., Ayres, A. M., Auriel, E., van Etten, E. S., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23830 · Cited by 160
Cheng, Y.-W., Chen, T.-F., & Chiu, M.-J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s123428 · Cited by 150
Ushering in the study and treatment of preclinical Alzheimer disease
Langbaum, J. B. S., Fleisher, A., Chen, K., Ayutyanont, N., Lopera, F. J., Quiroz, Y. T., Caselli, R. J., Tariot, P. N., & Reiman, E. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.107 · Cited by 149
Snitz, B. E., Weissfeld, L. A., Cohen, A. D., Lopez, O. L., Nebes, R. D., Aizenstein, H. J., McDade, E., Price, J. C., Mathis, C. A., & Klunk, W. E. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.01.008 · Cited by 140
Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging
Pankratz, V. S., Roberts, R. O., Mielke, M. M., Knopman, D. S., Jack, C. R., Geda, Y. E., Rocca, W. A., & Petersen, R. C. (2015) · Neurology · doi:10.1212/wnl.0000000000001437 · Cited by 150
Self-citationSubjective cognitive decline as a predictor of future cognitive decline: a systematic review
Parfenov, V. A., Zakharov, V. V., Кабаева, А. Р., & Васильевна, В. Н. (2020) · Dementia & Neuropsychologia · doi:10.1590/1980-57642020dn14-030007 · Cited by 131
Predicting future rates of tau accumulation on PET
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Botha, H., Graff-Radford, J., Jones, D. T., Ferman, T. J., et al. (2020) · Brain · doi:10.1093/brain/awaa248 · Cited by 117
Self-citationHarrington, M. G., Chiang, J., Pogoda, J. M., Gomez, M. E., Thomas, K., Marion, S., Miller, K. J., Siddarth, P., Yi, X., Zhou, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079378 · Cited by 118
[18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
Whitwell, J. L., Graff‐Radford, J., Tosakulwong, N., Weigand, S. D., Machulda, M. M., Senjem, M. L., Schwarz, C. G., Spychalla, A. J., Jones, D. T., Drubach, D. A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25142 · Cited by 95
Self-citationGrill, J. D., Raman, R., Ernstrom, K. B., Sultzer, D. L., Burns, J. M., Donohue, M., Johnson, K. A., Aisen, P. S. S., Sperling, R. A., Karlawish, J. H., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2734 · Cited by 101
Yue, L., Wang, T., Wang, J., Li, G., Wang, J., Li, X., Li, W., Hu, M., & Xiao, S. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00226 · Cited by 97
Buckley, R. F., Mormino, E. C., Chhatwal, J. P., Schultz, A. P., Rabin, J. S., Rentz, D. M., Acar, D., Properzi, M. J., Dumurgier, J., Jacobs, H. I. L., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.019 · Cited by 89
Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD
Wolk, D. A., Mancuso, L., Kliot, D., Arnold, S. E., & Dickerson, B. C. (2013) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.02.014 · Cited by 84
Imaging Brain Effects of APOE4 in Cognitively Normal Individuals Across the Lifespan
Fouquet, M., Besson, F. L., Gonneaud, J., Joie, R. L., & Chételat, G. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9263-8 · Cited by 89
Tosun, D., Veitch, D. P., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Petersen, R. C., Saykin, A. J., Bollinger, J., Ovod, V., Mawuenyega, K. G., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab008 · Cited by 86
Self-citationMRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
ten Kate, M., Redolfi, A., Peira, E., Bos, I., Vos, S. J., Vandenberghe, R., Gabel, S., Schaeverbeke, J., Scheltens, P., Blin, O., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0428-1 · Cited by 78
López‐Sanz, D., Garcés, P., Álvarez, B., Delgado‐Losada, M. L., López-Higes, R., & Maestú, F. (2017) · International Journal of Neural Systems · doi:10.1142/s0129065717500411 · Cited by 79
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
Epelbaum, S., Genthon, R., Cavedo, E., Habert, M. O., Lamari, F., Gagliardi, G. P., Lista, S., Teichmann, M., Bakardjian, H., Hampel, H. J., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.003 · Cited by 82
Lista, S., Garaci, F., Ewers, M., Teipel, S. J., Zetterberg, H., Blennow, K., & Hampel, H. J. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.04.506 · Cited by 78
Individualized clinical management of patients at risk for Alzheimer's dementia
Isaacson, R., Hristov, H., Saif, N., Hackett, K., Hendrix, S. B., Melendez, J., Safdieh, J. E., Fink, M. E., Thambisetty, M., Sadek, G., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.08.198 · Cited by 77
Chiotis, K., Saint‐Aubert, L., Boccardi, M., Gietl, A. F., Picco, A., Varrone, A., Garibotto, V., Herholz, K., Nobili, F. M., Nordberg, A. K., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.012 · Cited by 75
Self-citationRamanan, V. K., Castillo, A. M., Knopman, D. S., Graff‐Radford, J., Lowe, V. J., Petersen, R. C., Jack, C. R., Mielke, M. M., & Vemuri, P. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.13909 · Cited by 74
Self-citationHollands, S., for the AIBL Research Group, Lim, Y. Y., Buckley, R., Pietrzak, R. H., Snyder, P. J., Ames, D., Ellis, K. A., Harrington, K., Lautenschlager, N., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140678 · Cited by 67
Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: a meta-analysis
Coughlan, G. T., Klinger, H. M., Boyle, R., Betthauser, T. J., Binette, A. P., Christenson, L., Chadwick, T., Hansson, O., Harrison, T. M., Healy, B., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.0013 · Cited by 69
Self-citationHigh-level gait and balance disorders in the elderly: a midbrain disease?
Demain, A., Westby, G. W. M., Fernández-Vidal, S., Karachi, C., Bonneville, F., Do, M. C., Delmaire, C., Dormont, D., Bardinet, É., Agid, Y., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7174-x · Cited by 65
Association between Various Brain Pathologies and Gait Disturbance
Wennberg, A. M. V., Savica, R., & Mielke, M. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000456541 · Cited by 66
Self-citationMichels, L., Warnock, G., Buck, A., Macauda, G., Leh, S. E., Kaelin, A. M., Riese, F., Meyer, R., Tuura, R., Höck, C., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15605847 · Cited by 63
Verfaillie, S. C. J., Timmers, T., Slot, R. E. R., van der Weijden, C. W. J., Wesselman, L. M. P., Prins, N. D., Sikkes, S. A. M., Yaqub, M., Dols, A., Lammertsma, A. A., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00007 · Cited by 63
Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
Wolfsgruber, S., Jessen, F., Koppara, A., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H. J., Heuser, I., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001399 · Cited by 63
Physical activity, inflammation, and volume of the aging brain
Braskie, M. N., Boyle, C. P., Rajagopalan, P., Gutman, B. A., Toga, A. W., Raji, C. A., Tracy, R. P., Kuller, L. H., Becker, J. T., López, O. L., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.005 · Cited by 67
Joie, R. L., Perrotin, A., Egret, S., Pasquier, F., Tomadesso, C., Mézenge, F., Desgranges, B., Sayette, V. D. L., & Chételat, G. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.005 · Cited by 64
Characteristics of subjective cognitive decline associated with amyloid positivity
Janssen, O., Jansen, W. J., Vos, S. J. B., Boada, M., Parnetti, L., Gabryelewicz, T., Fladby, T., Molinuevo, J. L., Villeneuve, S., Hort, J., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12512 · Cited by 58
Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline
Rodríguez‐Gómez, O., Ruiz, C. A., Jessen, F., Valero, S., & Boada, M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150189 · Cited by 57
Clinical Trials in Predementia Stages of Alzheimer Disease
Pillai, J. A., & Cummings, J. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.01.002 · Cited by 58
Practice Effects and Amyloid Deposition
Duff, K. M., Foster, N. L., & Hoffman, J. M. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000021 · Cited by 56
Lista, S., Molinuevo, J. L., Cavedo, E., Rami, L., Amouyel, P., Teipel, S. J., Garaci, F., Toschi, N., Habert, M.-O., Blennow, K., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150202 · Cited by 53
Subjective Memory Complaints in APOE ɛ 4 Carriers are Associated with High Amyloid-β Burden
Zwan, M. D., Villemagne, V. L., Doré, V., Buckley, R. F., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150446 · Cited by 55
Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer’s disease
Habib, M., Mak, E., Gabel, S., Su, L., Williams, G., Waldman, A., Wells, K., Ritchie, K., Ritchie, C., & O’Brien, J. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.03.004 · Cited by 53
study, O. B. O. T. F., de Rojas, I., Romero, J., Rodríguez‐Gómez, O., Pesini, P., Sanabria, Á., Pérez‐Cordón, A., Ruiz, C. A., Hernández, I., Rosende‐Roca, M., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0444-1 · Cited by 55
Quantitative Water Permeability Mapping of Blood-Brain-Barrier Dysfunction in Aging
Ford, J. N., Zhang, Q., Sweeney, E. M., Merkler, A. E., de Leon, M. J., Gupta, A. K., Nguyen, T. D., & Ivanidze, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.867452 · Cited by 53
Insel, P. S., Palmqvist, S., Mackin, R. S., Nosheny, R. L., Hansson, O., Weiner, M. W., Mattsson, N., & Initiative, A. D. N. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.07.002 · Cited by 52
Kuhn, E., Moulinet, I., Perrotin, A., La Joie, R., Landeau, B., Tomadesso, C., Bejanin, A., Sherif, S., De La Sayette, V., Desgranges, B., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0514-z · Cited by 51
Buckley, R. F., Villemagne, V. L., Masters, C. L., Ellis, K. A., Rowe, C. C., Johnson, K. A., Sperling, R. A., & Amariglio, R. E. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0810-z · Cited by 51
Emerging biomarkers and screening for cognitive frailty
Ruan, Q., D’Onofrio, G., Sancarlo, D., Greco, A., Lozupone, M., Seripa, D., Panza, F., & Yu, Z. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0741-8 · Cited by 53
Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
Sasikumar, S., & Strafella, A. P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00047 · Cited by 58
Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment
Wolfsgruber, S., Wagner, M., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H. J., Heuser, I., Peters, O., Reischies, F. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100812 · Cited by 49
A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment
Kim, S. E., Woo, S., Kim, S. W., Chin, J., Kim, H. J., Lee, B. I., Park, J., Park, K. W., Kang, D., Noh, Y., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180048 · Cited by 46
Amyloid and Tau Biomarkers in Subjective Cognitive Impairment
Colijn, M. A., & Grossberg, G. T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150180 · Cited by 51
Grill, J. D., Hoang, D. K., Gillen, D. L., Cox, C. G., Gombosev, A., Klein, K. G., O’Leary, S., Witbracht, M. G., & Pierce, A. L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180069 · Cited by 49
Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?
Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Senjem, M. L., Lowe, V. J., Gunter, J. L., Boeve, B. F., Knopman, D. S., Dickerson, B. C., Petersen, R. C., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.01.006 · Cited by 47
Self-citationGogniat, M. A., Robinson, T. L., & Miller, L. S. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.025 · Cited by 50
Leinonen, V., Rinne, J. O., Virtanen, K. A., Eskola, O., Rummukainen, J., Huttunen, J., zu Fraunberg, M. V. U., Nerg, O., Koivisto, A. M., Rinne, J., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12102 · Cited by 43
on behalf of the Euro-SCD working group, Wolfsgruber, S., Molinuevo, J. L., Wagner, M., Teunissen, C. E., Rami, L., Coll‐Padrós, N., Bouwman, F. H., Slot, R. E. R., Wesselman, L. M. P., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0463-y · Cited by 43
Neuroimaging predictors of brain amyloidosis in mild cognitive impairment
Tosun, D., Joshi, S. C., & Weiner, M. W. (2013) · Annals of Neurology · doi:10.1002/ana.23921 · Cited by 43
A machine learning approach to screen for preclinical Alzheimer's disease
Gaubert, S., Houot, M., Raimondo, F., Ansart, M., Corsi, M., Naccache, L., Sitt, J. D., Habert, M., Dubois, B., Fallani, F. D. V., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.024 · Cited by 43
Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD
Schultz, S. A., Boots, E. A., Darst, B. F., Zetterberg, H., Blennow, K., Edwards, D. F., Koscik, R. L., Carlsson, C. M., Gallagher, C. L., Bendlin, B. B., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003862 · Cited by 41
The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease
Ghadery, C., Koshimori, Y., Christopher, L., Kim, J., Rusjan, P., Lang, A. E., Houle, S., & Strafella, A. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01714-6 · Cited by 42
Whitwell, J. L., Ahlskog, J. E., Tosakulwong, N., Senjem, M. L., Spychalla, A. J., Petersen, R. C., Jack, C. R., Lowe, V. J., & Josephs, K. A. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.12.016 · Cited by 40
Self-citationAnsart, M., Epelbaum, S., Gagliardi, G. P., Olivier Colliot, A., Dormont, D., Dubois, B., Hampel, H. J., Durrleman, S., & Initiative, A. D. N. (2019) · Statistical Methods in Medical Research · doi:10.1177/0962280218823036 · Cited by 36
Gietl, A. F., Warnock, G., Riese, F., Kälin, A. M., Saake, A., Gruber, E., Leh, S. E., Unschuld, P. G., Kuhn, F. P., Burger, C., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.036 · Cited by 38
Buckley, R. F., Sikkes, S. A. M., Villemagne, V. L., Mormino, E. C., Rabin, J. S., Burnham, S. C., Papp, K. V., Doré, V., Masters, C. L., Properzi, M. J., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.08.004 · Cited by 33
Deep Learning Prediction of Mild Cognitive Impairment using Electronic Health Records
Fouladvand, S., Mielke, M. M., Vassilaki, M. E., Sauver, J. L. S., Petersen, R. C., & Sohn, S. (2019) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm47256.2019.8982955 · Cited by 34
Self-citationA History of Senile Plaques: From Alzheimer to Amyloid Imaging
Beach, T. G. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac030 · Cited by 37
Utility of the Cognitive Difficulties Scale and Association With Objective Test Performance
Buelow, M. T., Tremont, G. N., Frakey, L. L., Grace, J., & Ott, B. R. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514539032 · Cited by 33
Sakr, F. A., Grothe, M. J., Cavedo, E., Jelistratova, I., Habert, M., Dyrba, M., González‐Escamilla, G., Bertin, H., Locatelli, M., Lehéricy, S., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0466-3 · Cited by 32
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
Chételat, G., & Fouquet, M. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.025 · Cited by 32
Reimand, J., de Wilde, A., Teunissen, C. E., Zwan, M. D., Windhorst, A. D., Boellaard, R., Barkhof, F., van der Flier, W. M., Scheltens, P., van Berckel, B. N. M., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0561-5 · Cited by 31
Royse, S. K., Cohen, A. D., Snitz, B. E., & Rosano, C. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2021.685957 · Cited by 31
Horn, M. M., Kennedy, K. M., & Rodrigue, K. M. (2018) · Psychology and Aging · doi:10.1037/pag0000217 · Cited by 30
1 H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
Nedelská, Z., Przybelski, S. A., Lesnick, T. G., Schwarz, C. G., Lowe, V. J., Machulda, M. M., Kremers, W. K., Mielke, M. M., Roberts, R. O., Boeve, B. F., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004421 · Cited by 29
Self-citationRelevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline
Stark, M., Wolfsgruber, S., Kleineidam, L., Frommann, I., Altenstein, S., Bartels, C., Brosseron, F., Büerger, K., Burow, L., Butryn, M., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207844 · Cited by 28
The influence of demographic factors on subjective cognitive concerns and beta-amyloid
Aghjayan, S. L., Buckley, R. F., Vannini, P., Rentz, D. M., Jackson, J., Sperling, R. A., Johnson, K. A., & Amariglio, R. E. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216001502 · Cited by 28
Sex and Sleep Disruption as Contributing Factors in Alzheimer’s Disease
Johnson, C. E., Duncan, M. J., & Murphy, M. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230527 · Cited by 34
Mantovani, E., Martini, A., Dinoto, A., Zucchella, C., Ferrari, S., Mariotto, S., Tinazzi, M., & Tamburin, S. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00823-x · Cited by 29
Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes
Frey, K. A., & Petrou, M. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0104-4 · Cited by 27
Chow, B. C., Duong, T. V., Duong, T. V., HASSEL, H., Kwok, T. C. Y., Nguyen, M. H., & Liu, H. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1355392 · Cited by 28
Valkanova, V., & Ebmeier, K. P. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.02.016 · Cited by 27
Molecular Imaging of Alzheimer Disease Pathology
Kantarci, K. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3847 · Cited by 24
Recruiting to preclinical Alzheimer's disease clinical trials through registries
Grill, J. D. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.02.004 · Cited by 23
McDonough, I. M., McDougall, G. J., LaRocca, M. A., Dalmida, S. G., & Arheart, K. L. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1594160 · Cited by 23
Ashford, M. T., Veitch, D. P., Neuhaus, J. M., Nosheny, R. L., Tosun, D., & Weiner, M. W. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12253 · Cited by 23
Metadata
- Authors
- Mielke, M. M., Wiste, H. J., Weigand, S. D., Knopman, D. S., Lowe, V. J., Roberts, R. O., Geda, Y. E., Swenson-Dravis, D. M., Boeve, B. F., Senjem, M. L., Vemuri, P., Petersen, R. C., & Jack, C. R.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Neurology
- Published
- 2012-10-09
- Volume
- 79
- Issue
- 15
- Pages
- 1570-1577
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3475629
- OpenAlex
- W2004344916
- Cited by
- 163
- References
- 34
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 6 · 2023: 12 · 2022: 12 · 2021: 13 · 2020: 12 · 2019: 17 · 2018: 11 · 2017: 15 · 2016: 10 · 2015: 17 · 2014: 14 · 2013: 15 · 2012: 2
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Robert Wood Johnson Foundation
- Alzheimer's Association
- Eli Lilly and Company
- Pfizer (R01 AG034676)
- Baxter International
- Mayo Foundation for Medical Education and Research (AG034676, AG016574, R01-AG034676)
- European Commission
- Eisai
- National Institutes of Health (AG016574, AG034676, AG006786, AG011378)
- National Institute on Aging (R01AG034676, AG-034676, U01AG037526, AG016574, AG011378, U01AG006786, AG-006786, R01AG011378, K01AG028573, RO1 AG011378, R01AG041851, R01 AG0113, P50AG016574)
- National Institute of Mental Health (K01MH068351)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- cerebral amyloidosis, Pittsburgh compound B PET, preclinical Alzheimer's disease, cognitively normal elderly, APOE ε4, age as predictor, subjective memory complaints, screening biomarkers, number needed to screen, Mayo Clinic Study of Aging
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Apolipoproteins E, Brain, Brain Mapping, Cognition, Female, Genotype, Humans, Male, Neuropsychological Tests, Radionuclide Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
